The U.S. Postal Service today released a temporary final rule updating its Hazardous, Restricted and Perishable Mail regulations for Category B infectious substances “to support the rapid deployment” of COVID-19 diagnostic tests through the mail during the public health emergency.
In addition to updated packaging instructions, all shippers of COVID-19-related Infectious Substances Category B UN3373 must obtain authorization from the Postal Service prior to mailing, the rule states. “These measures are necessary to ensure that diagnostic kits potentially containing Category B Infectious Substances are packaged, marked and labelled properly to ensure safety and containment throughout transport.”
[embeddoc url=”https://www.postaltimes.com/wp-content/uploads/2020/04/2020-08256.pdf” download=”all” viewer=”google”]